货号:GS40820
Zilovertamab (formerly Cirmtuzumab; UC-961) is an investigational humanized monoclonal antibody that targets the Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1). It is being developed for the treatment of ROR1-expressing hematologic malignancies and solid tumors, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), aiming to block Wnt signaling and induce tumor cell death.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物